Cardiology

Filter

ISCHEMIA Trial: Blood Pressure Control Drives CV Risk Reduction in GDMT Strategy

April 2025

Early GDMT goals, especially blood pressure control, reduce the risk of CV events in chronic coronary disease.

EMJ

New Catheter Development Allows Doctors to Look Inside Arteries

A HIGH-TECH catheter has recently been successful in allowing cardiologists to see inside patients’ arteries for the first time during procedures to…

Janssen Receives CHMP Positive Opinion for STELARA® (Ustekinumab) Recommending Approval for the Treatment of Moderately to Severely Active Crohn’s Disease in the European Union

Belgium, September 16, 2016 – Janssen-Cilag International NV (“Janssen”) announced today that the Committee for Medicinal Products for Human Use (CHMP)…

EMJ

Electric Mesh Device Could Save the Heart from Failure

AN INNOVATIVE electric mesh device that wraps around the heart to transport electrical impulses has been used to improve cardiac function in experimental…

EMJ

Strong Immune System Could Protect from Heart Attack

RESEARCHERS have discovered a link between higher levels of certain antibodies and a lower risk of heart attack excluding other risk factors, in patients…

Introducing EMJ Hematology 4.1

United Kingdom, July 28, 2016: Welcome to EMJ Hematology. This edition provides a wide selection of peer-reviewed articles exploring the emerging issues…

Richard Wolf Presents Its Profile at the 24th International Congress of the E.A.E.S in Amsterdam

June 16, 2016 – Particularly in contemporary medicine, the importance of efficient processes is steadily increasing on account of the rising pressure…

iVascular Completes Recruitment of Patients for Its ANCHOR Clinical Trial of the Sirolimus Eluting Stent ANGIOLITE

May 19, 2016 – Coordinated by PI Dr. Josep Rodés-Cabau from Quebec Heart and Lung Institute, the objective of ANCHOR clinical trial is to perform a…

European Commission Approves TREVICTA®(Paliperidone Palmitate a 3-Monthly Injection), for Maintenance Treatment of Schizophrenia

BEERSE, BELGIUM, 31st May 2016 – Janssen-Cilag International NV announced today that the European Commission (EC) has approved the use of TREVICTA®…

Loading posts...

« Previous 1 … 28 29 30 31 32 … 36 Next »